SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,206,018 | +1.1% | 9,949 | -4.4% | 0.00% | 0.0% |
| Q2 2023 | $1,192,382 | -8.0% | 10,412 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $1,295,602 | -36.2% | 9,400 | -40.0% | 0.00% | -50.0% |
| Q4 2022 | $2,030,130 | +57.9% | 15,667 | +34.7% | 0.00% | +33.3% |
| Q3 2022 | $1,286,000 | +35.7% | 11,631 | -8.0% | 0.00% | +50.0% |
| Q2 2022 | $948,000 | +23.4% | 12,643 | +28.5% | 0.00% | +100.0% |
| Q1 2022 | $768,000 | -17.9% | 9,837 | -5.3% | 0.00% | -50.0% |
| Q4 2021 | $936,000 | -55.1% | 10,392 | -53.9% | 0.00% | -50.0% |
| Q3 2021 | $2,083,000 | -14.1% | 22,524 | -27.8% | 0.00% | -20.0% |
| Q2 2021 | $2,425,000 | +6.3% | 31,190 | +1.9% | 0.01% | 0.0% |
| Q1 2021 | $2,282,000 | +8.7% | 30,618 | +148.6% | 0.01% | 0.0% |
| Q4 2020 | $2,100,000 | +24.6% | 12,317 | +2.6% | 0.01% | 0.0% |
| Q3 2020 | $1,686,000 | -5.6% | 12,007 | +7.8% | 0.01% | -16.7% |
| Q2 2020 | $1,786,000 | +53.0% | 11,137 | -6.6% | 0.01% | +20.0% |
| Q1 2020 | $1,167,000 | -33.7% | 11,929 | -12.6% | 0.01% | -16.7% |
| Q4 2019 | $1,761,000 | +51.7% | 13,649 | -11.5% | 0.01% | +50.0% |
| Q3 2019 | $1,161,000 | -51.5% | 15,419 | -2.2% | 0.00% | -55.6% |
| Q2 2019 | $2,395,000 | +17.1% | 15,765 | -8.1% | 0.01% | +12.5% |
| Q1 2019 | $2,045,000 | +49.8% | 17,154 | +37.1% | 0.01% | +14.3% |
| Q4 2018 | $1,365,000 | -27.5% | 12,512 | +7.3% | 0.01% | -22.2% |
| Q3 2018 | $1,883,000 | +16.3% | 11,660 | -4.8% | 0.01% | +12.5% |
| Q2 2018 | $1,619,000 | +80.3% | 12,252 | +1.1% | 0.01% | +60.0% |
| Q1 2018 | $898,000 | -13.4% | 12,121 | -35.0% | 0.01% | -16.7% |
| Q4 2017 | $1,037,000 | -18.5% | 18,639 | -63.0% | 0.01% | -25.0% |
| Q3 2017 | $1,272,000 | +80.7% | 50,396 | +141.5% | 0.01% | +60.0% |
| Q2 2017 | $704,000 | +111.4% | 20,871 | +85.8% | 0.01% | +66.7% |
| Q1 2017 | $333,000 | +50.7% | 11,236 | +39.4% | 0.00% | +50.0% |
| Q4 2016 | $221,000 | -67.5% | 8,063 | -67.0% | 0.00% | -66.7% |
| Q3 2016 | $680,000 | – | 24,461 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |